My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Senseonics Holdings, Inc. Common Stock (NY:SENS)

0.4480 -0.0139 (-3.01%)
Official Closing Price Updated: 6:30 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Senseonics Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Senseonics Holdings, Inc. Reports First Quarter 2021 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings Has a Legitimate Chance in a Burgeoning Market
SENS stock is worth following in the growth sector of diabetes management devices and has growth ahead almost certainly. 
Via InvestorPlace
Advantage the Drift in Senseonics Stock Before It Recovers on FDA Nod
Take advantage of the drift in Senseonics before it recovers with a nod by the FDA nod. SENS stock will skyrocket after FDA approval. 
Via InvestorPlace
Why Senseonics Is An Intriguing Speculative Buy At These Levels
As far as speculative picks go, SENS stock is an intriguing option for investors looking for a speculative small cap play right now. 
Via InvestorPlace
Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
Senseonics Holdings Is a Worthy Niche Diabetes-Care Investment
You might never have considered investing in a glucose monitoring company, but SENS stock is a good name to consider for health-care investors. 
Via InvestorPlace
Can This Popular Reddit Stock Make You Rich?
Up over 250% in less than a year, what's behind the rise of this hot stock? 
Via The Motley Fool
Mulling Senseonics Holdings? Beware What Lurks On Its Balance Sheet
Senseonics develops glucose monitoring products. Thanks to Reddit, SENS stock is up 111% year-to-date. Here’s why you shouldn’t buy. 
Via InvestorPlace
Biotechs Aligning to Address Challenges for Developing Therapeutics for Billion Dollar Neurological Disorders Industry
Via FinancialNewsMedia
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom
Senseonics will rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next 5 years with FDA approval. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.